Generic drugmakers plan to work with distributors, wholesalers and others to create an advance warning system for medicines that are in short supply, the head of the U.S. generic industry's trade ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

Consumers' greater use of low-cost generic drugs to combat ever-higher medical bills has sparked a building boom that is creating more than 2,000 jobs at pharmaceutical manufacturers on Long Island.

Design switched from gray metal panels to red brick in response to complaints that prior facade would be drab and commercial-looking. The building is estimated to cost $120 million and take 26 months ...

In September 1984, the Drug Price Competition & Patent Term Restoration Act, commonly known as the Hatch-Waxman Act for its congressional sponsors’ names, was signed into U.S. law. By creating a new ...